Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embodied Interoception Questionnaire (Intero-10): Development, Validation, and Application in People With Neuropathic Chronic Pain.

European journal of pain (London, England)·2026
Same author

Ozzy Osbourne and Parkinson's disease: from darkness to awareness.

Arquivos de neuro-psiquiatria·2026
Same author

A Biological Framework for Parkinson's Disease: Advances in α-Synuclein-Centered Biomarkers and Staging.

Journal of neurochemistry·2026
Same author

Cortical connectivity abnormalities assessed by TMS-EEG in patients after a transient ischemic attack.

Neurophysiologie clinique = Clinical neurophysiology·2026
Same author

Amitriptyline for neuropathic pain in patients with leprosy: a bicenter randomized controlled trial.

Pain·2026
Same author

Patients with different putative chronic pain mechanisms have different cortical complexity and synchrony.

Pain·2026
Same journal

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Reply to Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K

Development and Validation of the Dystonia-Pain Classification System: A Multicenter Study.

Clarice Listik1, Eduardo Listik2, Flávia de Paiva Santos Rolim3

  • 1Department of Neurology, Movement Disorders Center, School of Medicine, University of São Paulo, São Paulo, Brazil.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 20, 2023
PubMed
Summary
This summary is machine-generated.

A new Dystonia-Pain Classification System (Dystonia-PCS) reliably categorizes chronic pain (CP) in dystonia patients. This validated tool aids in better pain management and clinical trial design for dystonia.

Keywords:
chronic paindystonianonmotor symptomspainpain classification

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.4K
Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

3.6K

Related Experiment Videos

Last Updated: Jun 14, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.4K
Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

3.6K

Area of Science:

  • Neurology
  • Pain Medicine
  • Clinical Assessment Tools

Background:

  • Chronic pain (CP) is a prevalent and disabling nonmotor symptom in dystonia, significantly impacting patients' quality of life (QoL).
  • A validated tool for assessing CP in dystonia is currently lacking, hindering effective pain management strategies.
  • Dystonia significantly affects daily living and overall well-being due to its associated symptoms.

Purpose of the Study:

  • To develop and validate a classification and scoring system for chronic pain (CP) specifically in dystonia patients.
  • To establish a reliable method for differentiating dystonia-related pain from unrelated pain.
  • To create a tool that quantifies the severity and impact of CP in the context of dystonia.

Main Methods:

  • A multidisciplinary group developed the Dystonia-Pain Classification System (Dystonia-PCS), classifying CP as related or unrelated to dystonia.
  • A pain severity score was developed, assessing intensity, frequency, and impact on daily living.
  • A cross-sectional, multicenter validation study recruited patients with inherited/idiopathic dystonia, comparing Dystonia-PCS with established pain, mood, QoL, and dystonia scales.

Main Results:

  • Chronic pain (CP) was present in 81 of 123 patients, with 82.7% directly related to dystonia.
  • The Dystonia-PCS demonstrated excellent reliability, with high intra-rater (ICC: 0.941) and inter-rater (ICC: 0.867) agreement.
  • Pain severity scores from Dystonia-PCS showed significant correlations with validated measures of pain, QoL, and mood.

Conclusions:

  • The Dystonia-Pain Classification System (Dystonia-PCS) is a reliable and validated tool for categorizing and quantifying chronic pain (CP) in dystonia.
  • This system will facilitate improved clinical trial design and enhance the management of CP in individuals with dystonia.
  • The development of Dystonia-PCS addresses a critical unmet need in the assessment and treatment of pain in dystonia.